| Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
 | 2020 | Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of
follow-up: A retrospective cohort study | Moreno-Pérez, Oscar; Andres, Mariano; LEON-RAMIREZ, JOSE-MANUEL; Sánchez-Payá, José; Rodríguez, Juan Carlos; Sánchez, Rosario; García Sevila, Raquel; Boix, Vicente; Gil, Joan; Merino, Esperanza |  |
 | 2020 | Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients | Moreno-Pérez, Oscar; LEON-RAMIREZ, JOSE-MANUEL; Fuertes Kenneally, Laura; Perdiguero, Miguel; Garcia-Navarro, Mar; Ruiz-Torregrosa, Paloma; Boix, Vicente; Gil, Joan; Merino, Esperanza; On behalf of COVID19-ALC Research Group | |
 | ago-2021 | Plasma ACE2 species are differentially altered in COVID-19 patients | García Ayllón, María Salud; Moreno Pérez, Óscar; García Arriaza, Juan; Ramos Rincón, José Manuel; Cortés Gómez, María Ángeles; Brinkmalm, Gunnar; Andrés Collado, Mariano Nicolás; León Ramírez, José Manuel; Boix Martínez, Vicente; Gil, Joan; Zetterberg, Henrik; Esteban, Mariano; Merino de Lucas, Esperanza | |
 | 2021 | Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study | Moreno-Pérez, Oscar; Merino, Esperanza; LEON-RAMIREZ, JOSE-MANUEL; Andres, Mariano; Ramos, Jose Manuel; Arenas-Jiménez, Juan; ASENSIO, SANTOS; Rosa, Sanchez; Ruiz-Torregrosa, Paloma; Galan, Irene; Scholz, Alexander; Amo, Antonio; González-delaAleja, Pilar; Boix, Vicente; Gil, Joan; On behalf of COVID19-ALC research group | |
.png){kind=logo}